Clinical Trials Logo

Digestive Neuroendocrine Tumors clinical trials

View clinical trials related to Digestive Neuroendocrine Tumors.

Filter by:
  • None
  • Page 1

NCT ID: NCT02465112 Terminated - Liver Metastases Clinical Trials

Metabolic Radiotherapy After Complete Resection of Liver Metastases in Patient With Digestive Neuroendocrine Tumor

TERAVECT
Start date: September 2015
Phase: Phase 3
Study type: Interventional

TERAVECT is a phase III randomized study of patients with digestive neuroendocrine tumors after complete surgical resection of liver metastases treated with In111-Pentetreotide-based adjuvant radiotherapy. In this study, targeted radionuclide therapy is used at an earlier stage of the disease.The objective is to target residual tumor cells and/or micrometastases which escaped surgical resection. Given the poor prognosis associated with recurrence, this treatment should prevent relapse.